• Product

  • Technology

  • About AIVIS

Smart AI Quantification
for Precision Medicine

/images/main/main-graphic-1.webp
/images/main/main-graphic-2.svg

Rapid, Reliable and Robust IHC Quantification for Precision Medicine

Qanti® IHC

Pathologists & Clinicians

Quantification for clinically useful IHC expression

Breast
ER/PR
HER2
Ki-67
NET
Ki-67
Thyroid
Ki-67
Gastric
HER2

Qanti® Discovery

Pharmaceutical companies & Researchers

Quantification for novel drug target IHC expression

Membrane
Necleus
CytoplasmUpcoming

Recent Publications

Assessment of established prognostic factors and artificial intelligence-based evaluation of tumor-infiltrating lymphocytes in oral tongue squamous cell carcinoma
Oral Oncology

Assessment of established prognostic factors and artificial intelligence-based evaluation of tumor-infiltrating lymphocytes in oral tongue squamous cell carcinoma

July 3, 2028
A Standardized Validation Framework of Ki-67 Digital Image Analysis Using a Public Dataset in Breast Cancer
ESMO Breast Cancer 2026

A Standardized Validation Framework of Ki-67 Digital Image Analysis Using a Public Dataset in Breast Cancer

May 6, 2026
AI-Based Quantification of Central Tumor-Infiltrating Lymphocytes to Predict Recurrence-Free Survival in Bladder Cancer TURB Specimens
USCAP 2026

AI-Based Quantification of Central Tumor-Infiltrating Lymphocytes to Predict Recurrence-Free Survival in Bladder Cancer TURB Specimens

March 21, 2026

Our Clients & Partners

Our Clients

Business Partners

Research Partners

Latest News

AIVIS Selected for Government’s "DIPS 1000+" Deep Tech Project to Advance ADC Biomarker Quantification

AIVIS Selected for Government’s "DIPS 1000+" Deep Tech Project to Advance ADC Biomarker Quantification

April 21, 2026
etnews
AIVIS Presents Two AI Studies on Cancer Treatment Response and Prognosis Prediction at USCAP 2026

AIVIS Presents Two AI Studies on Cancer Treatment Response and Prognosis Prediction at USCAP 2026

March 24, 2026
etnews
AimedBio Announces Strategic Investment and Joint Research with AIVIS in AI-Based Biomarker Quantification

AimedBio Announces Strategic Investment and Joint Research with AIVIS in AI-Based Biomarker Quantification

February 3, 2026
BioSpectator

For more information

banner

Copyright © AIVIS Inc. 2026

CONTACT

help@aivis.kr

+82-2-6378-2021

ADDRESS

6th & 8th floor, 238, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea

PRODUCT

Qanti® Overview

Qanti® Breast ER/PR

Qanti® Breast HER2

Qanti® Breast Ki-67

Qanti® NET Ki-67

Qanti® Thyroid Ki-67

Qanti® Gastric HER2

Qanti® Discovery

EXPLORE

Certification

Publication

Patent

News & Events

About Us

Recruiting

Privacy Policy